Overall rank by patents
#27,477
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Silver Creek Pharmaceuticals, Inc.
USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
10
Total patents granted
5
CPC technology areas
12.0
Avg claims per patent
+300%
5-year filing velocity
The verdict
Silver holds 10 US patents across 5 technology areas, rank #27,477 of 50,000 tracked assignees.
- #27,477
- of 50,000 US assignees by volume
- Top 72%
- by Innovation Score (28.7/100)
- 12.0
- avg claims per patent
- +300%
- filing velocity, last 5 yrs
Portfolio overview
Silver Creek Pharmaceuticals, Inc. has been granted 10 US utility patents between 2018 and 2024, placing Silver Creek Pharmaceuticals, Inc. at rank #27,477 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.0 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Silver Creek Pharmaceuticals, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Silver sits between Sigmagen, Inc. (10 patents, rank #27,473) and Simple Wishes Llc (10 patents, rank #27,481) - the closest US assignees by grant volume. The composite Innovation Score of 28.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Silver Creek Pharmaceuticals, Inc.'s 12.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Silver Creek Pharmaceuticals, Inc. against peers pursuing similar technology classes.
Who files at Silver's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sigmagen
Sigmagen, Inc.
10 patents
- Sihl
Sihl GmbH
10 patents
- Silatronix
Silatronix, Inc
10 patents
- Silicon Turbine S…
Silicon Turbine Systems, Inc.
10 patents
- Silverstream B V
Silverstream Technologies B.V.
10 patents
- Silverwell Techno…
Silverwell Technology Limited
10 patents
- Simless
Simless, Inc.
10 patents
- Simple Wishes
Simple Wishes LLC
10 patents
- Silver Creek Phar… ◀
Silver Creek Pharmaceuticals, Inc.
10 patents
What this shows Silver holds 10 patents at rank #27,477, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Silver
By rank, the assignees closest to #27,477 in granted patent volume.
- Sigmagen, Inc. #27,473 · 10 patents
- Sihl Gmbh #27,474 · 10 patents
- Silatronix, Inc #27,475 · 10 patents
- Silicon Turbine Systems, Inc. #27,476 · 10 patents
- Silverstream Technologies B.v. #27,478 · 10 patents
- Silverwell Technology Limited #27,479 · 10 patents
- Simless, Inc. #27,480 · 10 patents
- Simple Wishes Llc #27,481 · 10 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Silver's primary technology class.
- The Regents Of The University Of California 1,387 in class
- Novartis Ag 1,071 in class
- Merck Sharp & Dohme Llc 889 in class
- Bristol-myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board Of Regents Of The University Of Texas System 744 in class
- Hoffmann-la Roche Inc. 722 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 721 in class
Silver's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 2 | 20.0% |
| 2021 | 2 | 20.0% |
| 2023 | 2 | 20.0% |
| 2024 | 2 | 20.0% |
Which technologies does Silver Creek Pharmaceuticals, Inc. patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Silver Creek Pharmaceuticals, Inc. hold?
Silver Creek Pharmaceuticals, Inc. holds 10 US granted patents filed between 2018 and 2024, spanning 5 technology areas.
What is Silver Creek Pharmaceuticals, Inc.'s Innovation Score?
Silver Creek Pharmaceuticals, Inc. has an Innovation Score of 28.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Silver Creek Pharmaceuticals, Inc. focus on?
Silver Creek Pharmaceuticals, Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 10 patents. The company has filed patents in 5 CPC subclasses total.
Is Silver Creek Pharmaceuticals, Inc.'s patent filing rate increasing or decreasing?
Silver Creek Pharmaceuticals, Inc.'s recent filing velocity is +300% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Silver Creek Pharmaceuticals, Inc.'s patents?
Silver Creek Pharmaceuticals, Inc.'s patents average 12.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the Silver Creek Pharmaceuticals, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Silver's 10 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Silver ranks #27,477 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.